In addition, it is clinically characterized by joint pain, nighttime pain, functional impairment and limited movement [1, 2]
Based on Phase 2 data, retatrutide produces substantially greater weight loss than semaglutide (Ozempic/Wegovy)
The maintenance dose The maintenance dose is the ongoing dose of a medication after the dose adjustment or titration phase
Lavie Jr., MD, FACC, FACP, FCCP, professor of medicine, medical director of cardiac rehabilitation and preventive cardiology, director of the Exercise Testing Laboratory and staff cardiologist in the Echocardiographic Laboratory at the John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, told Cardiology Today